Future Developments and Challenges

Rabies

Volumn , Issue , 2003, Pages 473-479

  Jackson, Alan C ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 19444382284     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012379077-4/50017-1     Document Type: Chapter

References (30)

1. Centers for Disease Control and Prevention Human rabies prevention-United States, 1999: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbid. Mortal. Weekly Rep. 1999, 48(RR-1):1-21.
2. Champion J.M., Kean R.B., Rupprecht C.E., Notkins A.L., Koprowski H., Dietzschold B., Hooper D.C. The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure. J. Immunol. Methods 2000, 235:81-90.
3. Childs J.E., Curns A.T., Dey M.E., Real L.A., Feinstein L., Bjornstad O.N., Krebs J.W. Predicting the local dynamics of epizootic rabies among raccoons in the United States. Proc. Natl. Acad. Sci. USA 2000, 97:13666-13671.
4. Dobson A. Raccoon rabies in space and time. Proc. Natl. Acad. Sci. USA 2000, 97:14041-14043.
5. Fearneyhough M.G., Wilson P.J., Clark K.A., Smith D.R., Johnston D.H., Hicks B.N., Moore G.M. Results of an oral rabies vaccination program for coyotes. J. Am. Vet. Med. Assoc. 1998, 212:498-502.
6. Fishbein D.B., Robinson L.E. Rabies. New Engl. J. Med. 1993, 329:1632-1638.
7. Freedberg K.A., Losina E., Weinstein M.C., Paltiel A.D., Cohen C.J., Seage G.R., Craven D.E., Zhang H., Kimmel A.D., Goldie S.J. The cost-effectiveness of combination antiretroviral therapy for HIV disease. New Engl. J. Med. 2001, 344:824-831.
8. Hanlon C.A., Childs J.E., Nettles V.F. Article III: Rabies in wildlife. The National Working Group on Rabies Prevention and Control. J. Am. Vet. Med. Assoc. 1999, 215:1612-1619.
9. Hanna J.N., Carney I.K., Smith G.A., Tannenberg A.E.G., Deverill J.E., Botha J.A., Serafin I.L., Harrower B.J., Fitzpatrick P.F., Searle J.W. Australian bat lyssavius infection: A second human case, with a long incubation period. Med. J. Aust. 2000, 172:597-599.
10. Haupt W. Rabies: Risk of exposure and current trends in prevention of human cases. Vaccine 1999, 17:1742-1749.
11. Jackson A.C., Fenton M.B. Human rabies and bat bites (Letter). Lancet 2001, 357:1714.
12. Jaijaroensup W., Tantawichien T., Khawplod P., Tepsumethanon S., Wilde H. Postexposure rabies vaccination in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 1999, 28:913-914.
13. Linhart S.B., Flores Crespo R., Mitchell G.C. Control of vampire bats by means of an anticoagulant (Spanish). Bol. Oficina. Sanit. Panama 1972, 73:100-109.
14. MacInnes C.D., Smith S.M., Tinline R.R., Ayers N.R., Bachmann P., Ball D.G., Calder L.A., Crosgrey S.J., Fielding C., Hauschildt P., Honig J.M., Johnston D.H., Lawson K.F., Nunan C.P., Pedde M.A., Pond B., Stewart R.B., Voigt D.R. Elimination of rabies from red foxes in eastern Ontario. J. Wildlife Dis. 2001, 37:119-132.
15. McColl K.A., Tordo N., Aguilar Setien A.A. Bat lyssavirus infections. Rev. Sci. Tech. Off. Int. Epiz. 2000, 19:177-196.
16. Meslin F.-X., Fishbein D.B., Matter H.C. Rationale and prospects for rabies elimination in developing countries. Current Topics in Microbiology and Immunology, Vol. 187: Lyssaviruses 1994, 1-26. Springer-Verlag, Berlin. C.E. Rupprecht, B. Dietzschold, H. Koprowski (Eds.).
17. Modelska A., Dietzschold B., Sleysh N., Fu Z.F., Steplewski K., Hooper D.C., Koprowski H., Yusibov V. Immunization against rabies with plant-derived antigen. Proc. Natl. Acad. Sci. USA 1998, 95:2481-2485.
18. Noah D.L., Drenzek C.L., Smith J.S., Krebs J.W., Orciari L., Shaddock J., Sanderlin D., Whitfield S., Fekadu M., Olson J.G., Rupprecht C.E., Childs J.E. Epidemiology of human rabies in the United States, 1980 to 1996. Ann. Intern. Med. 1998, 128:922-930.
19. Nuovo G.J. PCR in Situ Hybridization: Protocols and Applications 1997, Lippincott-Raven, Philadelphia.
20. Pan American Health Organization/World Health Organization XI Inter-American Meeting, at the Ministerial Level, on Animal Health: Report of the VII Meeting of Directors of National Rabies Control Programs 1999, World Health Organization, Geneva.
21. Pan American Health Organization/World Health Organization XII Inter-American Meeting, at the Ministerial Level, on Health and Agriculture: Report of the VIII Meeting of Directors of National Rabies Control Programs in Latin America (REDIPRA) 2001, World Health Organization, Geneva.
22. Rosatte R., Donovan D., Allan M., Howes L.A., Silver A., Bennett K., MacInnes C., Davies C., Wandeler A., Radford B. Emergency response to raccoon rabies introduction into Ontario. J. Wildlife Dis. 2001, 37:265-279.
23. Thompson R.D., Mitchell G.C., Burns R.J. Vampire bat control by systemic treatment of livestock with an anticoagulant. Science 1972, 177:806-808.
24. Wandeler A.I., Rosatte R.C., Williams D., Lee T.K., Gensheimer K.F., Montero J.T., Trimarchi C.V., Morse D.L., Eidson M., Smith P.F., Hunter J.L., Smith K.A., Johnson R.H., Jenkins S.R., Berryman C. Update: Raccoon rabies epizootic-United States and Canada, 1999. Morbid. Mortal. Weekly Rep. 2000, 49:31-35.
25. Warrell M.J., Warrell D.A. Intradermal postexposure rabies vaccine regimens (Letter). Clin. Infect. Dis. 2000, 31:844-845.
26. World Health Organization Oral Immunization of Dogs against Rabies: Report of the Sixth WHO Consultation Organized with the Participation of the Office International des Epizooties (OIE), Geneva, Switzerland, July 24-25, 1995. WHO/EMC/ZDI/98.13 1998, 1-28. World Health Organization, Geneva.
27. World Health Organization Field Application of Oral Rabies Vaccines for Dogs: Report of a WHO Consultation Organized with the Participation of the Office International des Epizooties (OIE), Geneva, Switzerland, July 20-22, 1998. WHO/EMC/ZDI/98.15 1988, 1-22. World Health Organization, Geneva.
28. World Health Organization World Survey of Rabies No. 34 for the Year 1998 2000, World Health Organization, Geneva.
29. World Health Organization Report of the 4th International Symposium on Rabies Control in Asia. Organized by the Merieux Foundation with the Cosponsorship of the World Health Organization 2001, (in press), World Health Organization, Geneva.
30. Yusibov V., Modelska A., Steplewski K., Agadjanyan M., Weiner D., Hooper D.C., Koprowski H. Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. Proc. Natl. Acad. Sci. USA 1997, 94:5784-5788.